Biostem Technologies Inc
OTC:BSEM
Biostem Technologies Inc
OTC:BSEM
Price:
6.24
USD
-7.14%
Market Closed
Market Cap:
$104.7m
Balance Sheet
Balance Sheet Decomposition
Biostem Technologies Inc
Biostem Technologies Inc
Balance Sheet Decomposition is not available for
Biostem Technologies Inc
Biostem Technologies Inc
Balance Sheet
Biostem Technologies Inc
Biostem Technologies Inc
Currency: USD
| Dec-1998 | Dec-1999 | Dec-2010 | Dec-2011 | Dec-2016 | Dec-2017 | Dec-2020 | Dec-2021 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
23
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
23
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
11
|
106
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
11
|
105
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
2
|
|
| Other Current Assets |
0
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
|
| Total Current Assets |
0
|
3
|
0
|
0
|
0
|
0
|
1
|
1
|
13
|
134
|
|
| PP&E Net |
0
|
0
|
2
|
2
|
2
|
2
|
1
|
1
|
1
|
2
|
|
| PP&E Gross |
0
|
0
|
2
|
2
|
0
|
0
|
1
|
1
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
1
|
0
|
0
|
1
|
1
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Goodwill |
0
|
3
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
4
|
|
| Other Assets |
0
|
3
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
0
N/A
|
6
N/A
|
3
-56%
|
3
+29%
|
3
-7%
|
2
-26%
|
3
+12%
|
3
+3%
|
15
+431%
|
140
+864%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
0
|
4
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
0
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
2
|
2
|
|
| Short-Term Debt |
0
|
1
|
0
|
0
|
0
|
0
|
0
|
4
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
1
|
0
|
4
|
0
|
4
|
4
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
8
|
93
|
|
| Total Current Liabilities |
0
|
6
|
0
|
0
|
2
|
1
|
7
|
7
|
15
|
99
|
|
| Long-Term Debt |
0
|
2
|
0
|
0
|
0
|
1
|
2
|
1
|
0
|
0
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
1
N/A
|
8
+909%
|
0
N/A
|
0
N/A
|
2
N/A
|
2
-30%
|
8
+439%
|
8
-2%
|
16
+87%
|
100
+540%
|
|
| Equity | |||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
2
|
3
|
4
|
0
|
0
|
0
|
|
| Retained Earnings |
1
|
10
|
0
|
1
|
6
|
12
|
28
|
29
|
45
|
14
|
|
| Additional Paid In Capital |
1
|
8
|
3
|
4
|
6
|
10
|
19
|
24
|
44
|
55
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
|
| Total Equity |
1
N/A
|
2
-142%
|
3
N/A
|
3
+29%
|
1
-72%
|
1
-15%
|
6
N/A
|
6
+4%
|
1
+82%
|
41
N/A
|
|
| Total Liabilities & Equity |
0
N/A
|
6
N/A
|
3
-56%
|
3
+29%
|
3
-7%
|
2
-26%
|
3
+12%
|
3
+3%
|
15
+431%
|
140
+864%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
0
|
0
|
0
|
0
|
3
|
7
|
9
|
10
|
16
|
17
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Switch to:
Switch to:
See Also
Discover More
